Martinez Detention Facility, Martinez, California.
Psychiatr Serv. 2020 Dec 1;71(12):1297-1299. doi: 10.1176/appi.ps.202000213. Epub 2020 Oct 14.
The past decade has seen a renaissance of research interest into the psychotherapeutic potential of psychedelic compounds. In 2019, Oakland and Denver became the first two jurisdictions in the United States to decriminalize the possession of psychedelic-containing organisms. As research and public policy continue to evolve, it becomes increasingly plausible that psychedelics will become viable treatment options for psychiatric conditions. Psychiatrists should be integral to models of psychedelic prescription and patient management. The risk for adverse psychological and medical effects from psychedelic sessions necessitates psychiatric supervision. The literature on psychedelic-assisted psychotherapy may provide wisdom regarding practical aspects of managing patients' treatment sessions.
在过去的十年中，人们对迷幻化合物的心理治疗潜力产生了浓厚的研究兴趣。2019 年，奥克兰和丹佛成为美国首批将含有迷幻物质的生物体合法化的两个司法管辖区。随着研究和公共政策的不断发展，迷幻剂成为精神疾病治疗选择的可能性越来越大。精神科医生应该成为迷幻药物处方和患者管理模式的重要组成部分。迷幻药物治疗可能会带来不良的心理和医疗影响，因此需要精神科医生的监督。迷幻辅助心理治疗的文献可能为管理患者治疗过程提供实用方面的智慧。
